4.7 Review

Targeting WASF3 Signaling in Metastatic Cancer

Journal

Publisher

MDPI
DOI: 10.3390/ijms22020836

Keywords

WASF3; metastasis; cancer; signaling network; drug target

Funding

  1. NIH [R03DE028387, R01DE028351]

Ask authors/readers for more resources

WASF3 is a crucial regulator in promoting cancer cell invasion and metastasis, and targeting it at the transcription, protein stability, and phosphorylation levels holds promise for metastasis suppression regardless of the diverse genetic backgrounds associated with tumor development.
Increasing evidence indicates that cancer metastasis is regulated by specific genetic pathways independent of those controlling tumorigenesis and cancer growth. WASF3, a Wiskott-Aldrich syndrome protein family member, appears to play a major role not only in the regulation of actin cytoskeleton dynamics but also in cancer cell invasion/metastasis. Recent studies have highlighted that WASF3 is a master regulator and acts as a pivotal scaffolding protein, bringing the various components of metastatic signaling complexes together both spatially and temporally. Herein, targeting WASF3 at the levels of transcription, protein stability, and phosphorylation holds great promise for metastasis suppression, regardless of the diverse genetic backgrounds associated with tumor development. This review focuses on the critical and distinct contributions of WASF3 in the regulation of signal pathways promoting cancer cell invasion and metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available